PRVA - Privia Health Group, Inc. Stock Price, Fair Value and News

18.01USD-0.85 (-4.51%)Market Closed

Market Summary

USD18.01-0.85

Market Closed

-4.51%

PRVA Alerts

2 major insider sales recently.

PRVA Stock Price

View Fullscreen

PRVA RSI Chart

PRVA Valuation

Market Cap

2.1B

Price/Earnings (Trailing)

114.65

Price/Sales (Trailing)

1.27

EV/EBITDA

Price/Free Cashflow

35.27

PRVA Price/Sales (Trailing)

PRVA Profitability

EBT Margin

1.44%

Return on Equity

3.01%

Return on Assets

1.82%

Free Cashflow Yield

2.83%

PRVA Fundamentals

PRVA Revenue

Revenue (TTM)

1.7B

Rev. Growth (Yr)

7.5%

Rev. Growth (Qtr)

-5.8%

PRVA Earnings

Earnings (TTM)

18.7M

Earnings Growth (Yr)

-53.39%

Earnings Growth (Qtr)

-20.55%

Breaking Down PRVA Revenue

Last 7 days

-2.2%

Last 30 days

-7.1%

Last 90 days

-13.8%

Trailing 12 Months

-35.1%

How does PRVA drawdown profile look like?

PRVA Financial Health

Current Ratio

1.8

PRVA Investor Care

Shares Dilution (1Y)

3.16%

Diluted EPS (TTM)

0.16

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.7B	0	0	0
2023	1.4B	1.5B	1.6B	1.7B
2022	1.1B	1.2B	1.3B	1.4B
2021	817.7M	860.2M	904.6M	966.2M
2020	794.0M	801.7M	809.4M	817.1M
2019	0	0	0	786.4M
2018	0	0	0	657.6M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Privia Health Group, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 30, 2024	bartrum thomas	sold	-41,481	18.42	-2,252	-
Apr 30, 2024	morris matthew shawn	sold	-203,707	18.42	-11,059	-
Apr 30, 2024	mountcastle david	sold	-42,734	18.42	-2,320	evp & chief financial officer
Apr 30, 2024	mehrotra parth	sold	-225,074	18.42	-12,219	chief executive officer
Apr 02, 2024	mountcastle david	sold	-69,889	17.77	-3,933	evp & chief financial officer
Mar 11, 2024	sullivan william m	sold	-9,208	23.02	-400	-
Mar 08, 2024	fargis edward c	acquired	-	-	28,544	evp & general counsel
Mar 08, 2024	mehrotra parth	acquired	-	-	119,885	chief executive officer
Mar 08, 2024	mountcastle david	acquired	-	-	38,058	evp & chief financial officer
Mar 08, 2024	sullivan william m	sold	-163,858	23.03	-7,115	-

Which funds bought or sold PRVA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 08, 2024	EMERALD ADVISERS, LLC	reduced	-67.33	-16,355,400	6,294,760	0.25%
May 08, 2024	KBC Group NV	unchanged	-	-9,000	49,000	-%
May 08, 2024	STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	reduced	-54.8	-308,624	365,004	-%
May 08, 2024	GREAT LAKES ADVISORS, LLC	sold off	-100	-3,507,280	-	-%
May 08, 2024	TD Asset Management Inc	reduced	-39.69	-2,461,800	2,593,010	-%
May 08, 2024	COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS	added	0.08	-75,915	434,545	-%
May 08, 2024	US BANCORP \DE\	reduced	-15.29	-138,486	357,166	-%
May 08, 2024	Russell Investments Group, Ltd.	reduced	-25.49	-431	744	-%
May 08, 2024	Focused Wealth Management, Inc	sold off	-100	-41,454	-	-%
May 08, 2024	EMERALD MUTUAL FUND ADVISERS TRUST	reduced	-78.81	-15,336,300	3,372,240	0.18%

Are Funds Buying or Selling PRVA?

Are funds buying PRVA calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own PRVA

No. of Funds

PRVA Alerts

2 major insider sales recently.

Unveiling Privia Health Group, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	9.55%	11,278,334	SC 13G
Feb 13, 2024	goldman sachs group inc	0.0%	41,373	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 23, 2024	blackrock inc.	14.5%	17,124,181	SC 13G/A
Jul 07, 2023	blackrock inc.	12.1%	13,938,867	SC 13G
Jun 12, 2023	fmr llc	-	0	SC 13G
May 15, 2023	durable capital partners lp	7.9%	9,090,909	SC 13G
May 12, 2023	pamplona capital partners iii, l.p.	0%	0	SC 13G/A
Feb 14, 2023	pamplona capital partners iii, l.p.	15.5%	17,741,723	SC 13G/A
Feb 14, 2023	goldman sachs group inc	21.7%	24,824,660	SC 13G/A

Recent SEC filings of Privia Health Group, Inc.

View All Filings

Date Filed	Form Type	Document
May 09, 2024	10-Q	Quarterly Report
May 09, 2024	8-K	Current Report
May 02, 2024	4	Insider Trading
May 02, 2024	4	Insider Trading
May 02, 2024	4	Insider Trading
May 02, 2024	4	Insider Trading
Apr 30, 2024	144	Notice of Insider Sale Intent
Apr 30, 2024	144	Notice of Insider Sale Intent
Apr 30, 2024	144	Notice of Insider Sale Intent
Apr 30, 2024	144	Notice of Insider Sale Intent

Peers (Alternatives to Privia Health Group, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	466.7B	379.5B	10.30%	3.46%	30.38	1.23	12.96%	-25.81%
CI	99.7B	206.0B	-1.82%	33.22%	25.87	0.48	12.55%	-43.95%
HCA	84.3B	66.7B	-2.18%	15.50%	15.4	1.26	9.59%	-4.59%
CVS	69.9B	360.9B	-24.11%	-20.14%	9.54	0.19	9.07%	78.49%
CNC	41.4B	155.5B	6.79%	16.14%	15.15	0.27	6.34%	84.42%
DVA	12.1B	12.3B	2.88%	38.95%	14.83	0.98	5.77%	58.74%
UHS	11.9B	14.7B	3.23%	25.09%	14.57	0.81	7.99%	19.23%
MID-CAP
CHE	8.7B	2.3B	-8.08%	4.15%	30.66	3.79	5.96%	18.29%
ACHC	6.5B	3.0B	-7.64%	1.03%	-579.28	2.19	10.92%	-104.06%
AMN	2.3B	3.8B	0.76%	-34.62%	10.95	0.61	-27.73%	-52.50%
AMEH	2.2B	1.5B	-8.15%	19.83%	35.09	1.51	19.34%	40.15%
SMALL-CAP
ADUS	1.7B	1.1B	7.65%	29.55%	26.48	1.6	11.45%	30.74%
BKD	1.4B	3.0B	4.67%	77.04%	-7.95	0.45	4.98%	4.88%
BEAT	53.2M	-	-5.61%	-9.82%	-3.52	-	-	-1.05%
AMS	19.4M	21.3M	3.03%	6.99%	36.34	0.91	8.00%	-62.25%

Privia Health Group, Inc. News

Latest updates

Privia Health Group, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																			(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2018Q4
Revenue	-5.8%	415,243,000	440,828,000	417,282,000	413,351,000	386,276,000	364,424,000	342,899,000	335,536,000	313,801,000	275,333,000	251,524,000	225,756,000	213,607,000	213,699,000	207,170,000	183,264,000	212,942,000	-	-
Operating Expenses	-5.7%	414,420,000	439,408,000	411,746,000	406,372,000	379,562,000	362,175,000	347,473,000	340,786,000	325,348,000	294,680,000	264,333,000	418,943,000	205,700,000	209,537,000	198,627,000	177,085,000	206,446,000	-	-
S&GA Expenses	-2.6%	6,085,000	6,249,000	7,241,000	5,956,000	5,286,000	5,173,000	5,088,000	4,819,000	4,661,000	3,800,000	4,588,000	11,178,000	3,184,000	3,962,000	2,709,000	2,220,000	2,452,000	-	-
EBITDA Margin	-8.6%	0.02	0.03	0.03	0.02	0.01	-0.01	-0.03	-0.04	-0.22	-0.22	-0.22	-0.20	-	-	-	-	-	-	-
Interest Expenses	4.8%	2,984,000	2,848,000	2,894,000	817,000	1,813,000	1,152,000	285,000	-663,000	-232,000	-185,000	-292,000	-302,000	-291,000	-437,000	-504,000	-509,000	-467,000	-	-
Income Taxes	-62.2%	751,000	1,986,500	2,488,000	1,400,000	2,125,000	-13,447,000	-4,845,000	5,468,000	6,308,000	-7,643,000	-2,210,000	-20,004,000	2,000,000	-67,000	-8,561,000	500,000	700,000	-	-
Earnings Before Taxes	-10.8%	3,807,000	4,268,000	8,430,000	7,796,000	8,527,000	3,401,000	-4,289,000	-5,913,000	-11,779,000	-19,532,000	-13,101,000	-193,489,000	7,616,000	3,725,000	8,039,000	5,670,000	6,029,000	-	-
EBT Margin	-17.7%	0.01	0.02	0.02	0.01	0.00	-0.01	-0.03	-0.04	-0.22	-0.23	-0.22	-0.20	-	-	-	-	-	-	-
Net Income	-20.6%	2,984,000	3,756,000	5,643,000	6,360,000	6,402,000	18,517,500	1,624,000	-11,381,000	-18,087,000	-11,612,500	-9,115,000	-173,485,000	5,616,000	3,949,000	16,685,000	5,196,000	5,329,000	-	-
Net Income Margin	-16.9%	0.01	0.01	0.02	0.02	0.01	-0.01	-0.03	-0.04	-0.20	-0.20	-0.19	-0.17	-	-	-	-	-	-	-
Free Cashflow	-151.7%	-33,160,000	64,078,000	22,443,000	7,535,000	-13,384,000	29,139,000	16,129,000	7,178,000	-5,354,000	-12,471,000	62,454,000	7,004,000	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet															(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2019Q4
Assets	3.2%	1,032	1,000	992	938	875	793	808	745	723	686	632	597	348	329	270
Current Assets	3.9%	728	701	698	654	589	552	580	521	493	447	469	436	205	190	130
Cash Equivalents	-9.9%	351	390	330	318	311	348	317	292	316	321	362	300	82.00	85.00	47.00
Net PPE	-12.3%	2.00	2.00	3.00	3.00	3.00	3.00	4.00	4.00	4.00	5.00	4.00	4.00	5.00	5.00	6.00
Goodwill	0.6%	140	139	136	135	8.00	127	127	127	128	8.00	8.00	119	119	119	119
Liabilities	4.1%	409	393	401	366	319	274	317	278	265	236	227	208	199	185	163
Current Liabilities	4.4%	404	387	394	358	310	264	305	265	220	190	187	167	158	147	115
Shareholder's Equity	10.9%	623	561	545	571	557	499	491	467	458	450	405	389	149	144	107
Retained Earnings	1.5%	-190	-193	-196	-202	-209	-216	-234	-236	-225	-208	-196	-187	-14.48	-19.88	-51.10
Additional Paid-In Capital	1.6%	766	754	740	726	721	715	704	680	660	634	606	579	166	166	160
Shares Outstanding	0.4%	119	118	118	117	115	115	109	109	108	103	102	99.00	-	-	-
Minority Interest	0.2%	46.00	46.00	46.00	46.00	43.00	20.00	21.00	22.00	23.00	23.00	-5.60	-3.83	-2.88	-3.10	-2.76
Float	-	-	-	-	2,200	-	-	-	1,470	-	-	-	1,420	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																			(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2018Q4
Cashflow From Operations	-151.7%	-33,137	64,101	22,461	7,607	-13,384	29,154	16,145	7,217	-5,320	-12,320	62,651	7,203	-2,476	-3,339	35,540	13,769	-7,079	-	-
Share Based Compensation	2.0%	11,904	11,669	10,801	9,247	5,381	9,175	14,833	18,470	24,881	25,070	25,800	202,560	101	121	121	121	121	-	-
Cashflow From Investing	-13.7%	-5,713	-5,023	-13,020	-72.00	-24,856	-15.00	-16.00	-39.00	-34.00	-32,379	-197	-199	-	-	-1.00	-366	-13.00	-	-
Cashflow From Financing	1031.0%	475	42.00	3,005	-819	1,477	1,957	8,574	-30,913	705	3,164	-93.00	210,809	-219	-219	-10,110	-438	10,000	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

PRVA Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue	$ 1,657,737	$ 1,356,660	$ 966,220
Operating expenses:
Provider expense	1,298,573	1,051,040	727,827
Cost of platform	197,663	170,838	174,731
Sales and marketing	24,732	19,741	22,750
General and administrative	109,587	129,592	255,884
Depreciation and amortization	6,533	4,571	2,464
Total operating expenses	1,637,088	1,375,782	1,183,656
Operating income (loss)	20,649	(19,122)	(217,436)
Interest (income) expense, net	(8,372)	(542)	1,070
Income (loss) before provision for (benefit from) income taxes	29,021	(18,580)	(218,506)
Provision for (benefit from) income taxes	7,993	(6,516)	(27,857)
Net income (loss)	21,028	(12,064)	(190,649)
Less: Loss attributable to non-controlling interests	(2,051)	(3,479)	(2,419)
Net income (loss) income attributable to Privia Health Group, Inc.	$ 23,079	$ (8,585)	$ (188,230)
Net income (loss) income per share attributable to Privia Health Group, Inc. stockholders – basic (in dollars per share)	$ 0.20	$ (0.08)	$ (1.83)
Net income (loss) income per share attributable to Privia Health Group, Inc. stockholders – diluted (in dollars per share)	$ 0.19	$ (0.08)	$ (1.83)
Weighted average common shares outstanding - basic (in shares)	116,731,406	110,695,266	102,952,370
Weighted average common shares outstanding – diluted (in shares)	124,686,067	110,695,266	102,952,370

PRVA Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 389,511	$ 347,992
Accounts receivable	290,768	189,604
Prepaid expenses and other current assets	20,525	14,366
Total current assets	700,804	551,962
Non-current assets:
Property and equipment, net	2,325	3,386
Right-of-use asset	6,612	8,089
Intangible assets, net	107,630	57,387
Goodwill	138,749	126,938
Deferred tax asset	35,200	40,368
Other non-current assets	8,580	4,683
Total non-current assets	299,096	240,851
Total assets	999,900	792,813
Current liabilities:
Accounts payable and accrued expenses	57,831	52,837
Provider liability	326,078	208,424
Operating lease liabilities, current	3,043	3,013
Total current liabilities	386,952	264,274
Non-current liabilities:
Operating lease liabilities, non-current	5,246	8,490
Other non-current liabilities	313	1,000
Total non-current liabilities	5,559	9,490
Total liabilities	392,511	273,764
Commitments and contingencies (Note 14)
Stockholders’ equity:
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 118,216,979 and 114,690,808 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	1,182	1,148
Additional paid-in capital	753,869	714,639
Accumulated deficit	(193,614)	(216,693)
Total Privia Health Group, Inc. stockholders’ equity	561,437	499,094
Non-controlling interest	45,952	19,955
Total stockholders’ equity	607,389	519,049
Total liabilities and stockholders’ equity	$ 999,900	$ 792,813

About Privia Health Group, Inc.

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.

CEO	Mr. Parth Mehrotra
WEBSITE	priviahealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	964

Privia Health Group, Inc. Frequently Asked Questions

What is the ticker symbol for Privia Health Group, Inc.? What does PRVA stand for in stocks?

PRVA is the stock ticker symbol of Privia Health Group, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Privia Health Group, Inc. (PRVA)?

As of Thu May 09 2024, market cap of Privia Health Group, Inc. is 2.14 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PRVA stock?

You can check PRVA's fair value in chart for subscribers.

What is the fair value of PRVA stock?

You can check PRVA's fair value in chart for subscribers. The fair value of Privia Health Group, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Privia Health Group, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PRVA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Privia Health Group, Inc. a good stock to buy?

The fair value guage provides a quick view whether PRVA is over valued or under valued. Whether Privia Health Group, Inc. is cheap or expensive depends on the assumptions which impact Privia Health Group, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PRVA.

What is Privia Health Group, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 09 2024, PRVA's PE ratio (Price to Earnings) is 96.36 and Price to Sales (PS) ratio is 1.29. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PRVA PE ratio will change depending on the future growth rate expectations of investors.